Protodesnitazene
| Protodesnitazene | |
|---|---|
| Molecular structure via molpic based on CDK |
| Physical properties [] | |
|---|---|
| Molecular mass | 365.5 g/mol [1] |
| Predicted LogP | 5 [1] |
| Structural Identifiers [] | |
|---|---|
| Molecular formula | C23H31N3O [1] |
| IUPAC name | N,N-diethyl-2-[2-[(4-propoxyphenyl)methyl]benzimidazol-1-yl]ethanamine [1] |
| SMILES | CCCOC1=CC=C(C=C1)CC2=NC3=CC=CC=C3N2CCN(CC)CC [1] |
| InChI | InChI=1S/C23H31N3O/c1-4-17-27-20-13-11-19(12-14-20)18-23-24-21-9-7-8-10-22(21)26(23)16-15-25(5-2)6-3/h7-14H,4-6,15-18H2,1-3H3 [1] |
| InChIKey | CEHFMRGBRNNSCM-UHFFFAOYSA-N [1] |
Protodesnitazene (also known as 1H-Benzimidazole-1-ethanamine, N,N-diethyl-2-((4-propoxyphenyl)methyl)- or N,N-Diethyl-2-((4-propoxyphenyl)methyl)-1H-benzimidazole-1-ethanamine) is a opioid substance of the nitazene class.
Chemistry
Stereochemistry []
Protodesnitazene is a achiral mixture.
Subjective effects []
See also []
External links []
References []
National Center for Biotechnology Information. PubChem Compound Summary for CID 157010653, Protodesnitazene. Accessed June 7, 2026. https://pubchem.ncbi.nlm.nih.gov/compound/157010653
U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Protodesnitazene. UNII: 3U89F8KB95. Global Substance Registration System. Accessed June 7, 2026. https://gsrs.ncats.nih.gov/ginas/app/beta/substances/3U89F8KB95